KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Assets Average (2016 - 2025)

Historic Assets Average for Amgen (AMGN) over the last 16 years, with Q4 2025 value amounting to $90.4 billion.

  • Amgen's Assets Average fell 109.18% to $90.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $90.4 billion, marking a year-over-year decrease of 109.18%. This contributed to the annual value of $91.2 billion for FY2025, which is 347.53% down from last year.
  • According to the latest figures from Q4 2025, Amgen's Assets Average is $90.4 billion, which was down 109.18% from $89.0 billion recorded in Q3 2025.
  • Amgen's 5-year Assets Average high stood at $95.1 billion for Q1 2024, and its period low was $59.2 billion during Q2 2022.
  • Its 5-year average for Assets Average is $78.7 billion, with a median of $88.8 billion in 2025.
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 5105.83% in 2023, then plummeted by 469.56% in 2025.
  • Over the past 5 years, Amgen's Assets Average (Quarter) stood at $63.1 billion in 2021, then increased by 2.11% to $64.4 billion in 2022, then soared by 45.7% to $93.8 billion in 2023, then decreased by 2.65% to $91.4 billion in 2024, then dropped by 1.09% to $90.4 billion in 2025.
  • Its Assets Average stands at $90.4 billion for Q4 2025, versus $89.0 billion for Q3 2025 and $88.6 billion for Q2 2025.